Pharmatest Services has purchased two new devices for bone imaging, the SkyScan 1276 high-resolution desktop in vivo Micro-computed tomography (mCT) system of Bruker and the Faxitron UltraFocus dual-energy X-ray absorptiometry (DXA) digital radiography system of DatecMedico.
Pharmatest Services is a contract research organisation offering preclinical efficacy services for the pharmaceutical industry in the fields of oncology and skeletal disease. Bone imaging has an important role in the services offered by the company.
SkyScan 1276 high-resolution desktop in vivo mCT system of Bruker was launched in September. It addresses the latest needs of preclinical imaging in animal studies by reducing the radiation dose while maintaining highest image quality and spatial resolution.
The Faxitron Ultrafocus DXA digital radiography system of DatecMedico improves the quality and resolution of in vivo X-ray images with an additional option of measuring bone mass density (BMD), bone mineral content (BMC), and lean and fat mass percentages.
CEO of Pharmatest Jussi Halleen comments: "This new equipment will further improve our strong bone imaging capabilities and provide added value to both our skeletal disease and oncology studies. They allow us to offer our customers high-quality follow-up data in rats and mice using latest and most advanced imaging technologies."